TY - JOUR T1 - FOXP3 mRNA profile prognostic of T cell mediated rejection and human kidney allograft survival JF - medRxiv DO - 10.1101/2020.04.28.20083493 SP - 2020.04.28.20083493 AU - Danny Luan AU - Darshana M. Dadhania AU - Ruchuang Ding AU - Thangamani Muthukumar AU - Michelle Lubetzky AU - John R. Lee AU - Vijay K. Sharma AU - Phyllis August AU - Franco B. Mueller AU - Joseph E. Schwartz AU - Manikkam Suthanthiran Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/02/2020.04.28.20083493.abstract N2 - Background and objectives T cell mediated rejection (TCMR) is the most frequent type of acute rejection and is associated with kidney allograft failure. Almost 40% of TCMR episodes fail to respond to anti-rejection therapy. FOXP3 is a specification factor for regulatory T cells and our single center study of 83 kidney allograft recipients showed that urinary cell FOXP3 mRNA level is diagnostic of TCMR and predicts TCMR reversibility and allograft survival. The objective of the current study is to determine whether our original findings could be replicated in an independent cohort of 480 kidney allograft recipients enrolled in the multicenter Clinical Trials of Organ Transplantation (CTOT)-04.Design, setting, participants, and measurements We measured levels of FOXP3 mRNA and levels of mRNA for CD25, CD3E, and perforin, and 18S rRNA in 3559 urines from 480 kidney allograft recipients prospectively enrolled in CTOT-04. RNA was isolated from the urinary cells and preamplification-enhanced real-time quantitative PCR assays were used to measure mRNAs.Results 18S rRNA normalized levels of mRNA for FOXP3 (P=0.01, Kruskal-Wallis test), CD25 (P=0.01), CD3E (P<0.0001), and perforin (P<0.0001) distinguished patients with TCMR biopsies from those with No Rejection biopsies and those with stable graft function. FOXP3 mRNA level, but not the levels of mRNA for CD25, CD3E, or perforin, predicted TCMR reversal (AUC=0.764; 95% confidence interval, 0.611 to 0.917; P=0.008). Multivariable logistic regression analysis showed that FOXP3 mRNA level remains predictive after adjustment for potential cofounders. Kaplan-Meier survival curve analysis showed that FOXP3 mRNA level (P=0.0306) but not the levels of mRNA for CD25, CD3E, or perforin, is associated with kidney allograft survival.Conclusion In the independent CTOT-04 cohort, we demonstrate that urinary cell level of FOXP3 mRNA is diagnostic of TCMR, predicts its reversibility, and is prognostic of kidney allograft survival following an episode of TCMR.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis investigation was supported by awards from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (RO1 AI072790 and R37 AI051652 to MS). The Clinical Trials in Organ Transplantation Study-04 (ClinicalTrials.gov NCT00337220) was supported by an award (UO1AI63589) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health to Abraham Shaked, University of Pennsylvania School of Medicine, Philadelphia, PA.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. ER -